Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
RSC Med Chem ; 12(8): 1312-1324, 2021 Aug 18.
Article in English | MEDLINE | ID: mdl-34458737

ABSTRACT

After antibiotic treatment, a subpopulation of bacteria often remains and can lead to recalcitrant infections. This subpopulation, referred to as persisters, evades antibiotic treatment through numerous mechanisms such as decreased uptake of small molecules and slowed growth. Membrane perturbing small molecules have been shown to eradicate persisters as well as render these populations susceptible to antibiotic treatment. Chemotype similarities have emerged suggesting amphiphilic heteroaromatic compounds possess ideal properties to increase membrane fluidity and such molecules warrant further investigation as effective agents or potentiators against persister cells.

2.
ChemMedChem ; 16(16): 2487-2490, 2021 08 19.
Article in English | MEDLINE | ID: mdl-33755337

ABSTRACT

3-Alkylpyridine alkaloids (3-APAs) isolated from the arctic sponge Haliclona viscosa are a promising group of bioactive marine alkaloids. However, due to limited bioavailability, investigations of their bioactivity have been hampered. Additionally, synthesis of a common intermediate requires the use of protecting groups and harsh conditions. In this work, we developed a simple and concise two-step route to nine different natural and synthetic haliclocyclins. These compounds displayed modest antibiotic activity against several Gram-positive bacterial strains.


Subject(s)
Alkaloids/pharmacology , Anti-Bacterial Agents/pharmacology , Gram-Positive Bacteria/drug effects , Pyridines/pharmacology , Alkaloids/chemical synthesis , Alkaloids/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Dose-Response Relationship, Drug , Microbial Sensitivity Tests , Molecular Conformation , Pyridines/chemical synthesis , Pyridines/chemistry , Structure-Activity Relationship
3.
Tetrahedron Lett ; 622021 Jan 05.
Article in English | MEDLINE | ID: mdl-33390617

ABSTRACT

Our continued synthetic interest in this class of retinoids, CD437 and its analogs, against methicillin-resistant Staphylococcus aureus (MRSA) has brought us to explore further isosteric substitutions within the scaffold. Although our previous findings have shown promising activity against gram-positive pathogens, their therapeutic viability remained an issue. Specifically, through preliminary analysis, our best performing compound, analog 2, displayed low solubility within serum as well as high affinity for retinoid binding proteins with a concentration dependent relationship. To circumvent this issue, we proposed a class of analogs containing an azaborine substitution in place of the naphthalene moiety. Azaborines have a nitrogen-boron bond substituting a carbon-carbon double bond that alters the electronics of the parent scaffold. This motif has been explored successfully in cancer research but to the best of our knowledge has yet to be applied to antibiotics. Herein, we describe the synthesis of the desired analogs, antimicrobial activity, and surprising physiochemical properties.

4.
Bioorg Med Chem Lett ; 37: 127809, 2021 04 01.
Article in English | MEDLINE | ID: mdl-33516911

ABSTRACT

Recent advances in the development of quaternary ammonium compounds (QACs) have focused on new structural motifs to increase bioactivity, but significantly less studied has been the change from ammonium- to sulfonium-based disinfectants. Herein, we report the synthesis of structurally analogous series of quaternary ammonium and trivalent sulfonium compounds (TSCs). The bioactivity profiles of these compounds generally mirror each other, and the antibacterial activity of sulfonium-based THT-18 was found to be comparable to the commercial disinfectant, BAC. The development of these compounds presents a new avenue for further study of disinfectants to combat the growing threat of bacterial resistance.


Subject(s)
Bacteria/drug effects , Quaternary Ammonium Compounds/pharmacology , Sulfonium Compounds/pharmacology , Surface-Active Agents/pharmacology , Thiophenes/pharmacology , Dose-Response Relationship, Drug , Erythrocytes/drug effects , Erythrocytes/metabolism , Humans , Microbial Sensitivity Tests , Molecular Structure , Quaternary Ammonium Compounds/chemical synthesis , Quaternary Ammonium Compounds/chemistry , Structure-Activity Relationship , Sulfonium Compounds/chemical synthesis , Sulfonium Compounds/chemistry , Surface-Active Agents/chemical synthesis , Surface-Active Agents/chemistry , Thiophenes/chemical synthesis , Thiophenes/chemistry
5.
ChemMedChem ; 15(21): 1974-1984, 2020 11 04.
Article in English | MEDLINE | ID: mdl-32886856

ABSTRACT

The prevalence of quaternary ammonium compounds (QACs) as common disinfecting agents for the past century has led bacteria to develop resistance to such compounds. Given the alarming increase in resistant strains, new strategies are required to combat this rise in resistance. Recent efforts to probe and combat bacterial resistance have focused on studies of multiQACs. Relatively unexplored, however, have been changes to the primary atom bearing positive charge in these antiseptics. Here we review the current state of the field of both phosphonium and sulfonium amphiphilic antiseptics, both of which hold promise as novel means to address bacterial resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Infective Agents, Local/pharmacology , Bacteria/drug effects , Drug Resistance, Bacterial/drug effects , Quaternary Ammonium Compounds/pharmacology , Surface-Active Agents/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Anti-Infective Agents, Local/chemical synthesis , Anti-Infective Agents, Local/chemistry , Drug Development , Microbial Sensitivity Tests , Quaternary Ammonium Compounds/chemical synthesis , Quaternary Ammonium Compounds/chemistry , Surface-Active Agents/chemical synthesis , Surface-Active Agents/chemistry
6.
Tetrahedron Lett ; 61(23)2020 Jun 04.
Article in English | MEDLINE | ID: mdl-32528190

ABSTRACT

In recent work, asymmetric conjugate addition reactions to chiral 4-phenyl-N-enoyl-1,3-oxazolidinones have been shown to give different stereochemical outcomes depending on the conditions employed. Through the application of stereodivergent reaction conditions, the total synthesis of (+)-pilosinine and the formal synthesis of (-)-pilosinine has been completed from a single enantiomer of the 1,3-oxazolidi-none auxiliary.

7.
ACS Infect Dis ; 6(7): 1553-1557, 2020 07 10.
Article in English | MEDLINE | ID: mdl-32412231

ABSTRACT

A novel virus named Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) emerged from Wuhan, China in late 2019. Since then, the virus has quickly spread worldwide, leading the World Health Organization to declare it as a pandemic; by the end of April 2020, the number of cases exceeded 3 million. Due to the high infectivity rate, SARS-CoV-2 is difficult to contain, making disinfectant protocols vital, especially for essential, highly trafficked areas such as hospitals, grocery stores, and delivery centers. According to the Centers for Disease Control and Prevention, best practices to slow the spread rely on good hand hygiene, including proper handwashing practices as well as the use of alcohol-based hand sanitizers. However, they provide warning against sanitizing products containing benzalkonium chloride (BAC), which has sparked concern in both the scientific community as well as the general public as BAC, a common quaternary ammonium compound (QAC), is ubiquitous in soaps and cleaning wipes as well as hospital sanitation kits. This viewpoint aims to highlight the outdated and incongruous data in the evaluation of BAC against the family of known coronaviruses and points to the need for further evaluation of the efficacy of QACs against coronaviruses.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Benzalkonium Compounds/pharmacology , Betacoronavirus/drug effects , Coronavirus Infections/prevention & control , Disinfectants/pharmacology , Disinfection/methods , Hand Disinfection/methods , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Sanitation/methods , Betacoronavirus/chemistry , COVID-19 , Coronavirus Infections/virology , Humans , Membrane Lipids , Pneumonia, Viral/virology , SARS-CoV-2 , Treatment Outcome , Virus Replication/drug effects
8.
Bioorg Med Chem Lett ; 30(9): 127099, 2020 05 01.
Article in English | MEDLINE | ID: mdl-32171615

ABSTRACT

Our labs have demonstrated the activity of bithionol and synthetic retinoids against methicillin-resistant Staphylococcus aureus (MRSA), as well as their membrane-acting mechanism of action. However, the compounds lack activity in gram-negative species. Herein, we apply a known strategy for converting gram-positive agents into broad-spectrum therapies: addition of an alkylamine. By appending an alkylamine to the phenols of these known membrane disruptors, we test whether this approach is applicable to our compounds. Ultimately, biological testing in four MRSA strains and three gram-negative species showed abolished or diminished activity in all our analogs compared to their parent compounds and no gram-negative activity. Thus, we find that alkylamines would not elicit broad-spectrum activity from bithionol or CD437 derivatives.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bithionol/chemistry , Ethylamines/chemistry , Gram-Negative Bacteria/drug effects , Phenols/chemistry , Retinoids/chemistry , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...